中国生物制药又一款 1 类新药首次启动临床

丁香园 Insight 数据库
Oct 30

10 月 29 日,中国药物临床试验登记与信息公示平台显示,中国生物制药旗下泰德制药1 类新药注射用 TRD208 启动首个临床试验。截图来源:药物临床试验登记与信息公示平台TRD208 是一款非阿片类双模式长效镇痛1 类创新药,融合了神经传导阻滞和抗炎的双重机制,临床前数据显示其对于中度急性疼痛具有显著获益。中度急性疼痛通常由手术切口、内脏器官损伤或局部炎症引起,其疼痛高峰期一般出现在损伤后 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10